ACCURAY INCORPORATED (NASDAQ:ARAY) Files An 8-K Regulation FD Disclosure

ME Staff 8-k
-
0
ACCURAY INCORPORATED (NASDAQ:ARAY) Files An 8-K Regulation FD Disclosure

ACCURAY INCORPORATED (NASDAQ:ARAY) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.

On September 16, 2019, the Company issued a press release regarding the recent announcement by China’s Customs Tariff Commission of the State Council that, effective September 17, 2019 until September 16, 2020, medical linear accelerators will be excluded from the additional tariffs China imposed on U.S. products that began on August 23, 2018. A copy of this press release is included as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Item 7.01 disclosure, including Exhibit 99.1, is furnished to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1    Press Release dated September 16, 2019.


ACCURAY INC Exhibit
EX-99.1 2 d804238dex991.htm EX-99.1 EX-99.1 Exhibit 99.1   China Announces Tariff Exclusion for Medical Linear Accelerators SUNNYVALE,…
To view the full exhibit click here

About ACCURAY INCORPORATED (NASDAQ:ARAY)

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.